Analysis of energy loss mediated by an alpha-1 blocker in patients with benign prostatic hyperplasia using a virtual urethra processed from an endoscopic video image

J Endourol. 2012 Sep;26(9):1216-20. doi: 10.1089/end.2012.0078. Epub 2012 May 8.

Abstract

Purpose: To examine the efficacy of an alpha-1 blocker and its correlation to structural alteration of the prostatic urethra and the loss of energy in the urine flow using a virtual urethra processed from an endoscopic video image.

Materials and methods: Video images of the prostatic urethra were recorded during cystourethroscopy in 11 patients with benign prostatic hyperplasia (BPH) before and after treatment with an alpha-1 blocker, naftopidil. The three-dimensional (3D) structure of the prostatic urethra was reproduced from video files. Fluid dynamic analysis and hydraulic energy calculations were performed using the "virtual" 3D urethral images.

Results: In 9 of 11 patients studied, an 11% improvement in the loss of energy (range, 1%-82%) was seen. Alpha-1 blocker treatment mediated the disappearance or decrease of the bulky vortex formation in seven patients, which led to an improved urinary stream. A positive correlation was found between improved energy loss and residual urine volume (P=0.0312).

Conclusion: Alpha-1 blocker therapy led to a decreased energy loss in the urine flow in the prostatic urethra in relation to the improvement of clinical symptoms. The cystourethroscopy could be a tool to assess the urethral resistance in patients with BPH using image processing methodology.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / administration & dosage
  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Endoscopy*
  • Humans
  • Male
  • Naphthalenes / administration & dosage
  • Naphthalenes / pharmacology
  • Naphthalenes / therapeutic use
  • Piperazines / administration & dosage
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Prostatic Hyperplasia / drug therapy*
  • Prostatic Hyperplasia / physiopathology
  • Urethra* / drug effects
  • Urethra* / physiopathology
  • Urination / drug effects*
  • Urination / physiology*
  • Video Recording*

Substances

  • Adrenergic alpha-Antagonists
  • Naphthalenes
  • Piperazines
  • naftopidil